Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

Geert A Simkens1 Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands;2 Department of Surgery, Maastricht University Medical Centre, Maastricht, The NetherlandsCorrespondence[email protected]

Anne G W E Wintjens3 NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands

Koen P Rovers1 Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands

Simon W Nienhuijs1 Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands

Ignace H de Hingh1 Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands;4 GROW - School for Oncology and Development Biology, Maastricht University, Maastricht, The Netherlands

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date